Introduction: The study aimed to compare the incidence of cardiovascular events (CVEs) after donor nephrectomy (DN) and radical tumor nephrectomy (RN), according to an estimated glomerular filtration rate (eGFR), were evaluated over time. Materials and Methods: Follow-up was collected for DN who underwent surgery from 1998 to 2007 for CVE and renal function. All DN were matched for age to patients treated by RN or adenoma enucleation (control group), who were eligible for DN. eGFR was estimated using the Cockgroft-Gould formula. Patients with preoperative comorbidities were excluded. Results: Thirty DN (median age 48.9 years) were included with a median follow-up of 138.5 months (interquartile range 119-159). No significant differences in patients' characteristics were found preoperatively (p > 0.5). Four out of 30 DN developed a CVE (3 myocardial infarctions (MI), 1 stroke), 2 of 30 patients in the control group (both MI) and 8 of 30 RN patients (6 MI, 2 strokes, p > 0.05). Arterial hypertension developed in 14 DN (46.7%), in 12 (40%) after RN and in 15 controls. The CVE occurred after a median time of 68 months (5-231) and were related to a drop of ∼30% in the eGFR irrespective of the group. Conclusion: Decline of renal function after nephrectomy is the main risk factor for CVE. Close monitoring of renal function and new onset hypertension is warranted.

Journal Section:
Editor's choice
Keywords:
Cardiovascular events, Kidney donation, Long term follow-up, Loss of kidney function, Nephrectomy, Glomerular filtration rate
1.
Van Poppel H, et al: A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-552.
[PubMed]
https://doi.org/10.1016/j.eururo.2010.12.013
2.
Chronic Kidney Disease Prognosis Consortium, Matsushita K, et al: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-2081.
[PubMed]
https://doi.org/10.1016/S0140-6736(10)60674-5
3.
National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 suppl 1):S1-S266.
[PubMed]
4.
Girndt M, Trocchi P, Scheidt-Nave C, Markau S, Stang A: The prevalence of renal failure - results from the German health interview and examination survey for adults, 2008-2011 (DEGS1). Dtsch Arztebl Int 2016;113:85-91.
[PubMed]
https://doi.org/10.3238/arztebl.2016.0085
5.
Go AS, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
[PubMed]
https://doi.org/10.1056/NEJMoa041031
6.
McKiernan J, et al: Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002;59:816-820.
[PubMed]
https://doi.org/10.1016/S0090-4295(02)01501-7
7.
Sarnak MJ, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003;42:1050-1065.
[PubMed]
https://doi.org/10.1161/01.HYP.0000102971.85504.7c
8.
Huang WC, et al: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006;7:735-740.
[PubMed]
https://doi.org/10.1016/S1470-2045(06)70803-8
9.
Segev DL, et al: Perioperative mortality and long-term survival following live kidney donation. JAMA 2010;303:959-966.
[PubMed]
https://doi.org/10.1001/jama.2010.237
10.
Reese PP, et al: Selecting appropriate controls for kidney donors - reply. Am J Transplant 2015;15:287-288.
[PubMed]
https://doi.org/10.1111/ajt.13015
11.
Ibrahim HN, et al: Long-term consequences of kidney donation. N Engl J Med 2009;360:459-469.
[PubMed]
https://doi.org/10.1056/NEJMoa0804883
12.
Fehrman-Ekholm I, et al: Kidney donors live longer. Transplantation 1997;64:976-978.
[PubMed]
https://doi.org/10.1097/00007890-199710150-00007
13.
Okamoto M, et al: The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center. Transplantation 2010;89:1391-1395.
[PubMed]
https://doi.org/10.1097/TP.0b013e3181d9e17b
14.
Garg AX, et al: Cardiovascular disease in kidney donors: matched cohort study. BMJ 2012;344:e1203.
[PubMed]
https://doi.org/10.1136/bmj.e1203
15.
Mjoen G, et al: Long-term risks for kidney donors. Kidney Int 2014;86:162-167.
[PubMed]
https://doi.org/10.1038/ki.2013.460
16.
Neuhauser H, Thamm M, Ellert U: Blutdruck in deutschland 2008-2011. Ergebnisse der studie zur gesundheit erwachsener in eutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56:795-801.
[PubMed]
https://doi.org/10.1007/s00103-013-1669-6
17.
Krebs RK, Andreoni C, Ortiz V: Impact of radical and partial nephrectomy on renal function in patients with renal cancer. Urol Int 2014;92:449-454.
[PubMed]
https://doi.org/10.1159/000355609
18.
Roos FC, et al: Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm. Urology 2012;79:607-613.
[PubMed]
https://doi.org/10.1016/j.urology.2011.10.073
19.
Demirjian S, et al: Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival. J Urol 2014;192:1057-1062.
[PubMed]
https://doi.org/10.1016/j.juro.2014.04.016
20.
Lorenz MW, et al: Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-467.
[PubMed]
https://doi.org/10.1161/CIRCULATIONAHA.106.628875
© 2016 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2016
You do not currently have access to this content.